Biologic Medicines-Focused Comera Life Sciences Turns To SPAC For NASDAQ Debut
Comera Life Sciences Inc has agreed to go public through a merger with OTR Acquisition Corp (NASDAQ: OTRA), a blank-check company.
Benzinga ·
Benzinga
